J2920 HCPCS code: Injection, methylprednisolone sodium succinate, up to 40 mg
J2920 is the HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 40 mg. CMS terminated J2920 on 2024-03-31; do not bill it for later dates of service. In 2024 Medicare paid an average of $2.89 per service for J2920 across 29,027 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. Medicare volume fell 76% from 2022 to 2024 (120,760 to 29,027 services). In 2024, about 4,326 clinicians billed Medicare for J2920 for 13,617 beneficiaries; Florida, California, Texas accounted for 42% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 2024-04-01 |
| Terminated | 2024-03-31 |
Who bills J2920 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,326 |
| Medicare beneficiaries | 13,617 |
| States with claims | 45 |
| Share of services in top 3 states (Florida, California, Texas) | 42% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2920, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 120,760 | 42,196 | $4.13 | $3.19 |
| 2023 | 118,803 | 40,366 | $3.86 | $2.97 |
| 2024 | 29,027 | 13,617 | $4.07 | $2.89 |
States with the most J2920 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 6,543 | $3.01 |
| California | 3,315 | $3.00 |
| Texas | 2,317 | $2.86 |
| Arizona | 1,333 | $2.88 |
| Georgia | 1,332 | $2.68 |
What changed for J2920
- 1982-01-01: J2920 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2920?
J2920 is the HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 40 mg. Short descriptor: "Methylprednisolone injection".
How much does Medicare pay for J2920?
In 2024, the average Medicare payment was $2.89 per service (average allowed $4.07).
Does Medicare cover J2920?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J29 codes
- J2910 — Injection, aurothioglucose, up to 50 mg
- J2916 — Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919 — Injection, methylprednisolone sodium succinate, 5 mg
- J2930 — Injection, methylprednisolone sodium succinate, up to 125 mg
- J2940 — Injection, somatrem, 1 mg
- J2941 — Injection, somatropin, 1 mg
- J2950 — Injection, promazine hcl, up to 25 mg
- J2993 — Injection, reteplase, 18.1 mg
- J2995 — Injection, streptokinase, per 250,000 iu
- J2997 — Injection, alteplase recombinant, 1 mg
- J2998 — Injection, plasminogen, human-tvmh, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2920
- Watch J2920 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2920
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.